Twentieth anniversary of Walce in Turin
Date of the event:
The twentieth anniversary of Walce (Women Against Lung Cancer in Europe) is the four-day programme, from 5 to 8 November 2026, with which the association founded in Turin in 2006 celebrated twenty years of activity. The initiative brought together patients, caregivers, healthcare professionals, institutions and scientific societies around the theme of lung cancer prevention and treatment.[1]
Presentation
The programme was presented at a meeting at the Piedmont Regional Council by Silvia Novello, the association's president and professor of medical oncology at the University of Turin. Novello stated that the twenty years should not be seen as a finish line but as a milestone, recalling that the association's name stems from the fact that lung cancer figures among women are still rising; among future goals she pointed to strengthening primary prevention, extending screening for at-risk people and reducing inequalities in access to care.[1]
The events
The calendar included the eighth edition of Be Mutual Days, titled «Oncogene Driven Cancers: the new paradigm», held on 5 and 6 November at the Hotel NH Collection Torino Santo Stefano with international experts and accounts from patients and caregivers.[1] On Saturday 7 November, at the same venue, the scientific conference «Dalla ricerca alla cura: vent'anni di progressi e nuove sfide» («From research to treatment: twenty years of progress and new challenges») was held.[1]
From 7 to 8 November, in piazza Carlo Alberto, a stop was made by «Esci dal Tunnel. Non bruciarti il futuro» («Get out of the tunnel. Don't burn your future»), a national touring campaign promoted by Walce to raise awareness of the risks linked to smoking and of lung cancer prevention.[1]
Context
The initiative took place against a backdrop in which, according to the 2025 Aiom White Paper, lung cancer mortality has fallen over the last 10-15 years by up to 24%, with a sharper drop in the 20-49 age group (35.5% among men and 46.4% among women), while five-year survival remains at 16% for men and 23% for women, among the lowest of all cancers.[1]
Sources
- ANSA Piemonte — 5 November 2026